Vascular access thrombosis--what are the possibilities of intervention?
Mysliwiec
M
M
D000925:Anticoagulants / Q000627:therapeutic use; D002408:Catheters, Indwelling / Q000009:adverse effects*; D016207:Cytokines / Q000502:physiology; D006487:Hemostasis; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors; D012701:Serotonin / Q000502:physiology; D013927:Thrombosis / Q000209:etiology* / Q000628:therapy
D000925:Anticoagulants; D016207:Cytokines; D010975:Platelet Aggregation Inhibitors; D012701:Serotonin